Highlights BioStem Techn. OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 20:48:05 07/06/2024 BST			5-day change	1st Jan Change
7.39 ^USD	+0.54%		-5.38%	+26.11%

05-14	Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	MT
2023	NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	MT

Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	05-14	MT
NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	11/09/23	MT
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer	26/10/22	GL

No results for this search